ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1374	National Cancer Institute	Html	en	Stomach (Gastric) Cancer Screening (PDQ®)–Health Professional Version	For stomach (gastric) cancer, there is no standard or routine screening test for the general U.S. population. Review the evidence on the benefits and harms of screening for gastric cancer using barium-meal photofluorography, gastric endoscopy, or serum pepsinogen in this expert-reviewed summary.	immigrant ethnic populations 0.555723 routine screening 0.545026 population-based screening 0.55023 major type 0.538572 gastric adenomatous polyps 0.695374 versus unscreened individuals 0.55595 atrophic gastritis 0.615129 H. pylori 0.564647 distal stomach 0.538456 gastric cancer worldwide 0.720749 gastric carcinoma. 0.66881 diffuse type. 0.56645 pepsinogen levels 0.550707 gastric mortality 0.684336 gastric endoscopy 0.658667 sporadic gastric adenomas 0.698707 Low serum pepsinogen 0.556585 case-control studies 0.567568 coincident decrease 0.54268 gastric cancer mortality 0.786779 intestinal metaplasia 0.542939 tissue gastric lymphoma 0.689624 gastric lymphoma. 0.665709 screening study 0.547045 duodenal ulcer disease 0.55893	standard cut-off values 0.552573 familial adenomatous polyposis 0.560734 single referral center 0.552547 gastric body 0.665835 proton pump inhibitors 0.55184 common cancer 0.560082 national program 0.560036 screening program 0.548065 noncardia gastric carcinoma 0.695412 classifies H. pylori 0.563321 diffuse type 0.542605 gastric carcinoma 0.707449 indigestion change pepsinogen 0.555323 gastric cancer 0.921375 type gastric cancer 0.702788 intestinal type 0.629856 striking decrease 0.543352 pernicious anemia 0.567146 chronic atrophic gastritis 0.574769 gastric cancer. 0.695414 stomach cancer 0.550691 nonpolyposis colon cancer 0.578666 twofold decrease 0.54109 Gastric adenocarcinomas 0.6758	CLICK HERE
1461	National Cancer Institute	Html	en	Vaginal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of vaginal cancer.	ongoing clinical trials 0.85552 long time span 0.761526 vaginal carcinoma 0.951107 vaginal wall involvement 0.883409 prior hysterectomy 0.778571 vaginal cancer 0.818887 vaginal cancer. 0.807751 available staging tests 0.778942 upper vaginal lesions 0.893311 Regional lymph nodes 0.757227 concurrent chemotherapy 0.764946 clear cell carcinomas 0.789213 cervical cancer 0.899035 Vaginal adenosis 0.826312 vaginal carcinomas 0.846251 vaginal SCC patients 0.90084 treatment approaches 0.767338 women 0.767592 treatment 0.85362 AJCC staging system. 0.759072 vaginal vault 0.831513 case series 0.90433 utero DES exposure 0.803909 apical vagina 0.754218 vaginal intraepithelial neoplasia 0.874302	external-beam radiation 0.754266 treatment planning 0.776769 clear cell carcinoma 0.966645 clear cell adenocarcinoma 0.790722 vaginal cancers 0.837225 local modality therapies 0.783604 cervical cancer management 0.790278 noninvasive squamous cell 0.774465 relative efficacy 0.761447 Gy tumor dose 0.754907 vaginal clear cell 0.868627 disease 0.778359 precise staging criteria 0.772344 local control 0.818953 utero exposure 0.878366 Early stage tumors 0.815533 cervical intraepithelial neoplasia 0.792254 small case series 0.758482 insufficient dose penetration 0.75402 American Joint Committee 0.782817 locally advanced tumors 0.766917 Cervical Cancer Treatment 0.817322 surgical treatment options 0.788171 standard treatment 0.795403	CLICK HERE
1792	National Cancer Institute	Html	es	Náuseas y vómitos relacionados con el tratamiento del cáncer (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las náuseas y vómitos como complicaciones del cáncer o su tratamiento. Se plantean abordajes de tratamiento de las náuseas y vómitos.	radioterapia nombre 0.366149 Dexametasona Corticosteroides 0.345517 palonosetrón antagonistas 0.420992 siguientes tipos 0.357417 siguientes estrategias 0.348254 único signo 0.33198 causa náuseas 0.753796 National Cancer Institute 0.339057 determinados medicamentos 0.5578 siguientes riesgos 0.330997 quimioterapia nombre 0.555099 PDQ Acupuntura 0.392476 Instituto Nacional 0.371538	siguientes problemas 0.372583 siguientes factores 0.44966 Physician Data Query 0.449355 Lorazepam Benzodiazepinas 0.337793 vómitos tardíos 0.949937 siguientes características 0.461706 determinadas situaciones 0.34995 fosaprepitant antagonistas 0.342662 prometazina fenotiacinas 0.421253 PDQ Náuseas 0.567745 medicamento tipo 0.522815 flujo sanguíneo escaso 0.412994 haloperidol butirofenonas 0.346571	CLICK HERE
1827	National Cancer Institute	Html	es	Tratamiento de la leucemia linfocítica crónica (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfocítica crónica.	genetic features predict 0.402765 Davis Z 0.402966 Exp Med 0.403766 with chronic lymphocytic 0.453469 B-cell chronic lymphocytic 0.404152 Hamblin TJ 0.403993 Montserrat E 0.403191 patients with rai 0.4028 lymphocytic leukemia reveals 0.403683 O'Brien S 0.403439 Keating MJ 0.403308 granular lymphocytes 0.404274 patients with chronic 0.453881 terapia inmediata versus 0.402689 CD38 expression 0.404463 ZAP-70 expression 0.403246 La LLC 0.412195 cell chronic lymphocytic 0.409866 Lymphocytic Leukemia updating 0.403993 patients with 0.466989 early-stage chronic lymphocytic 0.403314 gene expression 0.402974 Shanafelt TD 0.404951 International Workshop 0.403274 leukemia treated with 0.403613	granular lymphocyte leukemia 0.40409 versus clorambucilo 0.403972 French Cooperative Group 0.402864 monoclonal b-cell lymphocytosis 0.404973 Loughran TP Jr 0.403102 prognostic features 0.40312 leukemia with 0.405469 immunoglobulin mutation genotype 0.402773 lymphocytic leukemia from 0.403953 high-risk features such 0.40263 chronic lymphoid leukemia 0.404328 granular lymphocytic leukemia 0.403581 VH mutation status 0.402969 T-cell chronic lymphocytic 0.403416 large granular lymphocyte 0.403546 Clin Oncol 0.457605 Catovsky D 0.410385 mutation status 0.410696 chronic lymphocytic leukemia 0.989679 chronic lymphocytic leukaemia 0.467178 with chronic lymphoid 0.403309 lymphocyte leukemia with 0.403276 following chemoimmunotherapy with 0.404045 features such as 0.402637	CLICK HERE
1913	National Cancer Institute	Html	es	Tratamiento del cáncer de testículo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de testículo.	estadio is 0.441617 siguientes procedimientos 0.287311 células madre 0.729809 orquiectomía inguinal 0.910567 Testicular Cancer 0.25752 Pronóstico intermedio 0.226624 tubos minúsculos 0.238436 menor frecuencia 0.216803 rayos x 0.232109 sistema urinario masculino 0.265452 Pronóstico adverso 0.227528 estadio ib 0.342087 estadio ia 0.340936 largo plazo 0.339676 enlace drugs approved 0.310101 ondas sonoras 0.236752 National Cancer Institute 0.216079	siguientes riesgos 0.21354 Instituto Nacional 0.230763 estadio iiia 0.333884 PDQ Tratamiento 0.233897 estadio iiic 0.330798 estadio iia 0.338825 estadio iic 0.337012 coriónica humana beta 0.516427 Physician Data Query 0.263764 distinta manera 0.239745 Antecedentes familiares 0.232829 túbulos minúsculos 0.234263 glándulas sexuales masculinas 0.271775 ganglios linfáticos distantes 0.736212 toma imágenes 0.223821 siguientes pruebas 0.248918	CLICK HERE
2020	National Cancer Institute	Html	es	Prevención del cáncer de cuello uterino (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre los factores que aumentarían el riesgo de presentar cáncer de cuello uterino y los enfoques que ayudarían a la prevención de esta enfermedad.	cervical intra-epithelial neoplasia 0.302624 Obstet Gynecol 0.303555 Lancet Infect Dis 0.302739 vacuna qHPV 0.302144 VPH vs 0.303877 cervical carcinoma 0.305011 cáncer invasor 0.318393 González A 0.303459 VPH oncógenos 0.304066 American Cancer Society 0.303348 case-control study 0.30305 Costa Rica Vaccine 0.302774 cervical neoplasia 0.303702 Schiffman M 0.30246 without cervical carcinoma 0.302609 risk factors 0.303566 collaborative reanalysis 0.305986 International Collaboration 0.302415 Estados Unidos 0.303742 vacuna 9vHPV 0.303595 cancer in 0.308272 Natl Cancer Inst 0.304144 cervical cancer 0.371053 vacuna vph 0.305378 North American multicohort 0.3021	9-valent hpv vaccine 0.303034 VPH Población Estimación 0.304092 Quadrivalent HPV Vaccination 0.302755 human papillomavirus 0.353991 vacuna nanovalente vlp 0.302596 risk among hiv-infected 0.30327 Bosch FX 0.30227 Castle PE 0.302445 Muñoz N 0.303856 Costa Rica 0.303541 collaboration prospective study 0.303065 Immune Defic Syndr 0.302422 multicohort collaboration prospective 0.302636 Adverse Pregnancy Outcomes 0.302449 Acquir Immune Defic 0.302422 epidemiological studies 0.313912 with cervical carcinoma 0.302983 vacuna vph-16 l1 0.302668 cervical intraepithelial neoplasia 0.304671 cuello uterino 0.985138 American multicohort collaboration 0.302442 Cancer In young 0.302413 vacuna bivalente tipo 0.302487 cancer risk 0.305603	CLICK HERE
2033	National Cancer Institute	Html	es	Prevención del cáncer de próstata (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre los factores que pueden influir en el riesgo de cáncer de próstata y sobre la investigación dirigida a la prevención de esta enfermedad.	Thompson IM 0.314327 accessed july 0.302228 results from 0.303565 Connolly JM 0.303382 Prostate Cancer Events 0.317969 habitantes hombres 0.302425 Cancer Statistics Review 0.317133 Ross RK 0.305958 Sin embargo 0.309562 grasas animales 0.30255 American Cancer Society 0.316034 dietary fat 0.303757 tumores gleason 0.303142 productos lácteos 0.302873 Cancer Rates 0.308415 EI aumento 0.303513 EI riesgo 0.304572 Prostate specific 0.303323 Estados Unidos 0.302842 Natl Cancer Inst 0.462208 Gleason DF 0.304482 cancer prevention trial 0.348935 menor riesgo 0.303815 Prostate Cáncer Prevention 0.30803 SEER Cancer Statistics 0.317438	investigation into cancer 0.307885 Bernstein L 0.303522 prostate cancer prevention 0.326581 Prostate Prevention Trial 0.304615 Tangen CM 0.304256 Kristal AR 0.303247 EI Prostate Cancer 0.311391 United States 0.314913 Prostate Cancer Clinical 0.31207 Cancer Facts 0.309636 Kolonel LN 0.303682 prostate lncap tumors 0.303282 among japanese 0.304198 Nutr Cancer 0.308752 National Cancer Institute 0.326849 Epidemiol Biomarkers Prev 0.307319 dutasterida vs 0.303715 antecedentes familiares 0.303019 fatty acids 0.303826 Prostate Cancer Survey 0.310986 Prostate visualization studies 0.303528 grasas alimenticias 0.316785 prostate cancer 0.996017 Rose DP 0.305512	CLICK HERE
2049	National Cancer Institute	Html	es	Trasplantes de células madre formadoras de sangre	Hoja informativa que explica los procedimientos, paso a paso, del trasplante de médula ósea y del trasplante de células madre de sangre periférica, así como sus riesgos y beneficios.	células madre 0.995824 efecto gvt 0.300369 trasplante autólogo 0.304497 PBSCT alogénicos 0.300755 llamadas antígenos 0.300572 frecuencia células madre 0.306001 bone marrow transplantation 0.300883 raros casos 0.300403 Sin embargo 0.307734 catéter venoso central 0.300806 Programa Nacional 0.300971 llamadas células madre 0.30624 largo plazo 0.300324 causa disminución 0.300351 seguro médico 0.300814	cubre be 0.300325 paciente transfusiones 0.301172 HLA compatibles mejora 0.301344 idéntico.  sin embargo 0.300876 antígenos hla 0.303269 stem cell transplantation 0.300928 programa be 0.300461 posibles efectos 0.301054 linfocitos t".  0.3004 atacan.  más 0.300461 GVHD aguda 0.300451 corto plazo 0.30031 sangre.  solo 0.300435 usa dosis 0.301797 tipo hla 0.300841	CLICK HERE
2973	National Cancer Institute	Video	en	Make Sure You Have What It Takes	Ready to quit smoking? Make sure you have what it takes. Visit teen.smokefree.gov.	02 0.414634 ElixirMediaProd 0.414568 CDC 0.732439 QuitSmokingCom 0.418054 Sperm 0.414461 Famous People 0.497717 body 0.415775 Anti Smoking Commercial 0.594002 Disease Control 0.79595 Michael 0.432529 List 0.414915 Belhus 0.420781 Story 0.414456 Ellie 0.41667 Smokers 0.569726 Asthma Attack 0.474832 Duration 0.939681 Home Alchemy 0.475983 Hollywood 0.417592 mutation 0.414755 Smoking Advice 0.525781 Men 0.414403 Unattractive Things 0.479984 basement 0.414589	Smoking Timeline 0.544895 Centers 0.483728 NHS Smokefree 0.484439 Allen Carr 0.481427 Unkle Adams 0.494687 Losers Game 0.480152 air 0.41576 Aadarsh Sharma 0.493771 Videos 0.414563 Prevention 0.483581 Chicken Egg 0.47424 Great Ads 0.480844 smoking 0.667373 Smoking PSA 0.536443 views 0.800457 Terrifying 0.418131 CDC Tips 0.549794 James 0.414466 Domonic Smith 0.486979 Quit Smoking 0.543911 COPD patient 0.483677 Olly 0.42117 Planet Nibiru 0.480348 Doritos Commercial Compilation 0.548737	CLICK HERE
4389	National Cancer Institute	Html	en	Sunlight	Exposure to UV radiation from the sun, sunlamps, and tanning booths causes early aging and skin damage that can lead to skin cancer. Find information, including tips, on how to protect your skin.	skin cancer 0.670141 sun visors 0.456822 shades 0.330644 early aging 0.476035 dark skin 0.458278 sources 0.329654 skin damage 0.480277 wide brim 0.466856 windshields 0.391235 mid-morning 0.329734 long pants 0.452301 skin 0.754109 SPF 0.373931 ice 0.356895 UPF 0.341366 clouds 0.329163 skin tones 0.597399 tips 0.329364 Wear sunglasses 0.448638 sun protection factor 0.555629 dark fabrics 0.445529 light skin tone 0.592307 hat 0.32822	pavement 0.327954 mind 0.357411 late afternoon 0.469796 light clothing 0.439637 Exposure 0.331467 sunscreen products 0.456996 windows 0.357118 neck 0.328307 people 0.384721 water 0.356986 UV radiation 0.940101 sand 0.362057 sunlight 0.380409 ultraviolet protection factor 0.576115 snow 0.359149 booths 0.335732 parts 0.327951 ages 0.329914 sunlamps 0.332236 time 0.329824 beds 0.330757 rays 0.330102	CLICK HERE